LTRN vs. ROKT
LTRN (Lantern Pharma Inc.) is a stock, while ROKT (SPDR S&P Kensho Final Frontiers ETF) is Industrials Equities fund tracking the S&P Kensho Final Frontiers Index. Over the past 5 years, LTRN returned -23.61%/yr vs 22.41%/yr for ROKT. At a 0.28 correlation, their price movements are largely independent.
Performance
LTRN vs. ROKT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LTRN achieves a 14.19% return, which is significantly lower than ROKT's 29.72% return.
LTRN
- 1D
- -3.89%
- 1M
- -10.82%
- 6M
- 2.98%
- YTD
- 14.19%
- 1Y
- -5.98%
- 3Y*
- -11.25%
- 5Y*
- -23.61%
- 10Y*
- —
ROKT
- 1D
- -2.22%
- 1M
- -8.09%
- 6M
- 13.55%
- YTD
- 29.72%
- 1Y
- 67.32%
- 3Y*
- 36.99%
- 5Y*
- 22.41%
- 10Y*
- —
LTRN vs. ROKT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
LTRN Lantern Pharma Inc. | 14.19% | -5.02% | -25.47% | -29.14% | -24.31% | -58.55% | 30.07% |
ROKT SPDR S&P Kensho Final Frontiers ETF | 29.72% | 50.56% | 27.89% | 14.41% | -0.81% | 4.63% | 19.15% |
Correlation
The correlation between LTRN and ROKT is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.33 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.29 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Jun 11, 2020 | 0.28 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LTRN vs. ROKT — Risk / Return Rank
LTRN
ROKT
LTRN vs. ROKT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Lantern Pharma Inc. (LTRN) and SPDR S&P Kensho Final Frontiers ETF (ROKT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LTRN | ROKT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.20 | ||
| Sortino ratioReturn per unit of downside risk | -2.13 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.34 | -0.25 |
| Calmar ratioReturn relative to maximum drawdown | -0.08 | 3.51 | -3.58 |
| Martin ratioReturn relative to average drawdown | -0.16 | 11.94 | -12.10 |
Loading charts...
Drawdowns
LTRN vs. ROKT - Drawdown Comparison
The maximum LTRN drawdown since its inception was -94.89%, which is greater than ROKT's maximum drawdown of -43.16%. Use the drawdown chart below to compare losses from any high point for LTRN and ROKT.
Loading charts...
Drawdown Indicators
| LTRN | ROKT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.89% | -43.16% | -51.73% |
Max Drawdown (1Y)Largest decline over 1 year | -78.95% | -19.30% | -59.65% |
Max Drawdown (3Y)Largest decline over 3 years | -89.48% | -23.46% | -66.02% |
Max Drawdown (5Y)Largest decline over 5 years | -92.50% | -23.46% | -69.04% |
Current DrawdownCurrent decline from peak | -84.22% | -19.30% | -64.92% |
Average DrawdownAverage peak-to-trough decline | -66.44% | -6.85% | -59.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 38.23% | 5.65% | +32.58% |
Volatility
LTRN vs. ROKT - Volatility Comparison
Lantern Pharma Inc. (LTRN) has a higher volatility of 26.54% compared to SPDR S&P Kensho Final Frontiers ETF (ROKT) at 10.83%. This indicates that LTRN's price experiences larger fluctuations and is considered to be riskier than ROKT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LTRN | ROKT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.54% | 10.83% | +15.71% |
Volatility (6M)Calculated over the trailing 6-month period | 91.71% | 26.34% | +65.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 99.45% | 31.74% | +67.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 86.09% | 23.47% | +62.62% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 85.25% | 25.43% | +59.82% |
Dividends
LTRN vs. ROKT - Dividend Comparison
LTRN has not paid dividends to shareholders, while ROKT's dividend yield for the trailing twelve months is around 0.28%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
LTRN Lantern Pharma Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ROKT SPDR S&P Kensho Final Frontiers ETF | 0.28% | 0.41% | 0.57% | 0.62% | 0.54% | 1.79% | 0.48% | 0.74% | 0.16% |
Frequently Asked Questions
LTRN and ROKT have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LTRN has higher volatility (26.54%) compared to ROKT (10.83%). In terms of maximum drawdown, LTRN dropped -94.89% vs ROKT's -43.16%.
ROKT currently has the higher Sharpe Ratio (2.14 vs -0.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LTRN and ROKT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer